期刊文献+

In vitro induction of specific anti-tumoral immunity against laryngeal carcinoma by using human interleukin-12gene-transfected dendritic cells 被引量:11

In vitro induction of specific anti-tumoral immunity against laryngeal carcinoma by using human interleukin-12gene-transfected dendritic cells
原文传递
导出
摘要 Background Objective evaluation of the antitumor effect of interleukin-12 (IL-12) gene-transfected dendritic cell (DC)vaccine on laryngeal carcinoma requires in vivo and in vitro tests. The aim of this study was to investigate the function of IL-12 gene transfected DC at initiating specific immune response to laryngeal carcinoma in vitro.Methods Recombinant adenovirus with IL-12 gene was constructed. DCs were isolated from the peripheral blood of patients with laryngeal carcinoma, pulsed with tumor lysate of laryngeal carcinoma cells (DC+Ag), and transfected with IL-12 (DC-IL-12+Ag). The cells pheotypes including CD83, CD86 and HLA-DR on surface of DCs were assayed by flow cytometry (FCM). The concentration of IL-12 in culture supernatant of DCs and interferon γ (IFN-γ) in culture supernatant of T cells cocultured with DCs were quantified by ELISA. Methyl thiazolys tetrazolium (MTT) was used to evaluate proliferation of autologous T lymphocytes and activation of cytotoxic T lymphocytes (CTL) stimulated by IL-12-transfected DCs pulsed with tumor lysate against laryngeal carcinoma cells.Results The recombinant adenovirus expressing IL-12 gene was constructed successfully. Gene-transfected DC plused with tumor lysate with IL-12 (DC-IL-12+Ag) expressed higher level of CD83, CD86 and produced higher level of IL-12 than untransfected DCs (DC+Ag) (CD83: (60.2±1.8)% vs. (50.7±1.2)%, P <0.05; CD86: (88.9±2.1)% vs.(78.2±3.9)%, P <0.05; IL-12: (262.5±3.0) ng/L vs. (103.8±5.1) ng/L, P <0.05). The proliferation of autologous T lymphocytes and production of IFN-γ stimulated by DC transfected with IL-12 were more obviously than untransfected DCs. Cytotoxicity of CTL stimulated by IL-12-transfected DC pulsed with tumor lysate against laryngeal carcinoma cells were significantly stronger than stimulated by untransfected DC.Conclusion It is a promising approach for IL-12-transfected DC pulsed with tumor lysate to increase the antitumoral effect. Background Objective evaluation of the antitumor effect of interleukin-12 (IL-12) gene-transfected dendritic cell (DC)vaccine on laryngeal carcinoma requires in vivo and in vitro tests. The aim of this study was to investigate the function of IL-12 gene transfected DC at initiating specific immune response to laryngeal carcinoma in vitro.Methods Recombinant adenovirus with IL-12 gene was constructed. DCs were isolated from the peripheral blood of patients with laryngeal carcinoma, pulsed with tumor lysate of laryngeal carcinoma cells (DC+Ag), and transfected with IL-12 (DC-IL-12+Ag). The cells pheotypes including CD83, CD86 and HLA-DR on surface of DCs were assayed by flow cytometry (FCM). The concentration of IL-12 in culture supernatant of DCs and interferon γ (IFN-γ) in culture supernatant of T cells cocultured with DCs were quantified by ELISA. Methyl thiazolys tetrazolium (MTT) was used to evaluate proliferation of autologous T lymphocytes and activation of cytotoxic T lymphocytes (CTL) stimulated by IL-12-transfected DCs pulsed with tumor lysate against laryngeal carcinoma cells.Results The recombinant adenovirus expressing IL-12 gene was constructed successfully. Gene-transfected DC plused with tumor lysate with IL-12 (DC-IL-12+Ag) expressed higher level of CD83, CD86 and produced higher level of IL-12 than untransfected DCs (DC+Ag) (CD83: (60.2±1.8)% vs. (50.7±1.2)%, P <0.05; CD86: (88.9±2.1)% vs.(78.2±3.9)%, P <0.05; IL-12: (262.5±3.0) ng/L vs. (103.8±5.1) ng/L, P <0.05). The proliferation of autologous T lymphocytes and production of IFN-γ stimulated by DC transfected with IL-12 were more obviously than untransfected DCs. Cytotoxicity of CTL stimulated by IL-12-transfected DC pulsed with tumor lysate against laryngeal carcinoma cells were significantly stronger than stimulated by untransfected DC.Conclusion It is a promising approach for IL-12-transfected DC pulsed with tumor lysate to increase the antitumoral effect.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第9期1357-1361,共5页 中华医学杂志(英文版)
关键词 laryngeal carcinoma INTERLEUKIN-12 adenovirus vector dendritic cells IMMUNOTHERAPY laryngeal carcinoma interleukin-12 adenovirus vector dendritic cells immunotherapy
  • 相关文献

参考文献15

  • 1Gao C,Pan J,Lu W,Zhang M,Zhou L,Tian J.In vitro evaluaton of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.Anticancer Drugs 2009; 20:807-814.
  • 2Nestle FO,Aliagic S,Gilliet M,Sun Y,Grabbe S,Dummer R,et al.Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells.Nat Med 1998; 4:328-332.
  • 3Chang AE,Redman BG,Whitfield JR,Nickoloff BJ,Braun TM,Lee PP,et al.A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer.Clin Cancer Res 2002; 8:1021-1032.
  • 4Matsuda K,Tsunoda T,Tanaka H,Umano Y,Tanimura H,Nukaya I,et al.Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide-pulsed dendritic cells.Cancer Immunol Immunother 2004; 53:609-616.
  • 5Nair SK,Morse M,Boczkowski D,Cumming RI,Vasovoic L,Gilboa E,et al.Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells.Ann Surg 2002; 235:540-549.
  • 6Geiger JD,Hutchinson RJ,Hohenkirk LF,McKenna EA,Yanik GA,Lavine JE,et al.Vaccination of pediatric solid tumor patients with tumorlysate-pulse ddendritic cells can expand specific T cell and mediate tumor regression.Cancer Res 2001; 61:8513-8519.
  • 7Zeuthen LH,Christensen HR,Frokiaer H.Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram negative bacteria.Clin Vaccine Immunol 2006; 13:365-375.
  • 8Kordi-Tamandani DM,Shekari M,Suri V.Interleukin-12Gene polymorphism and cervical cancer risk.Am J Clin Oncol 2009; 32:524-528.
  • 9Kikuchi T,Akasaki Y,Irie M,Homma S,Abe T,Ohno T.Results of a phase Ⅰ clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.Cancer Immunol Immunother 2001; 50:337-344.
  • 10Marten A,Renoth S,Heinicke T,Albers P,Pauli A,Mey U,et al.Allogeneic dendritic cells fused with tumor cells:preclinical results and outcome of a clinical phase Ⅰ/Ⅱ trial in patients with metastatic renal cell carcinoma.Hum Gene Ther 2003; 14:483-494.

同被引文献41

引证文献11

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部